Next-generation sequencing is a powerful tool that can identify mutations or fusions in a wide range of cancers, enabling physicians to provide targeted therapy to patients and improve outcomes.
In this vodcast, Professor Andrew Beggs discusses practical aspects of this technique from the clinical viewpoint.
Supported by: Illumina, Inc., and Eli Lilly and Company